|
DENND1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.01310087991169E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.02362604240625E-12 |
| Normal-vs-Stage2 |
1.49890000000763E-06 |
| Normal-vs-Stage3 |
7.58499999999884E-05 |
| Normal-vs-Stage4 |
4.616800E-04 |
| Stage1-vs-Stage2 |
9.990000E-01 |
| Stage1-vs-Stage3 |
3.292600E-01 |
| Stage1-vs-Stage4 |
8.753600E-01 |
| Stage2-vs-Stage3 |
4.938000E-01 |
| Stage2-vs-Stage4 |
8.880200E-01 |
| Stage3-vs-Stage4 |
5.509200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51949572316335E-11 |
| Normal-vs-AfricanAmerican |
1.17289999934655E-09 |
| Normal-vs-Asian |
4.297400E-03 |
| Caucasian-vs-AfricanAmerican |
8.414600E-01 |
| Caucasian-vs-Asian |
9.158400E-01 |
| AfricanAmerican-vs-Asian |
9.672000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.82130002588121E-09 |
| Normal-vs-Female |
1.681020E-03 |
| Male-vs-Female |
7.011900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.99700000039316E-07 |
| Normal-vs-Extreme_Weight |
5.91515725290037E-12 |
| Normal-vs-Obese |
2.43629999951978E-07 |
| Normal-vs-Extreme_Obese |
2.017500E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.668200E-01 |
| Normal_Weight-vs-Obese |
5.176000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.777600E-01 |
| Extreme_Weight-vs-Obese |
4.084500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.124200E-01 |
| Obese-vs-Extreme_Obese |
5.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.015970E-02 |
| Normal-vs-Age(41-60Yrs) |
3.39700001461551E-09 |
| Normal-vs-Age(61-80Yrs) |
8.83737527601625E-14 |
| Normal-vs-Age(81-100Yrs) |
1.89019999652373E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.416400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.822400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.487900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.663000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.552200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.28360003024153E-09 |
| Normal-VS-Type2 PRCC |
1.54470003455032E-09 |
| Normal-VS-KIRP CIMP |
3.955000E-01 |
| Normal-VS-Unclassified PRCC |
3.642400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.866600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.251400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.830410E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.820980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.564500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.403000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.02199995530594E-09 |
| Normal-vs-N1 |
4.604700E-03 |
| Normal-vs-N2 |
2.150400E-02 |
| N0-vs-N1 |
4.771700E-02 |
| N0-vs-N2 |
6.629000E-01 |
| N1-vs-N2 |
5.248200E-01 |
|
|
